135 related articles for article (PubMed ID: 33843428)
21. Digging deep into "dirty" drugs - modulation of the methylation machinery.
Pleyer L; Greil R
Drug Metab Rev; 2015 May; 47(2):252-79. PubMed ID: 25566693
[TBL] [Abstract][Full Text] [Related]
22. Sequential combination of decitabine and idarubicin synergistically enhances anti-leukemia effect followed by demethylating Wnt pathway inhibitor promoters and downregulating Wnt pathway nuclear target.
Li K; Hu C; Mei C; Ren Z; Vera JC; Zhuang Z; Jin J; Tong H
J Transl Med; 2014 Jun; 12():167. PubMed ID: 24923330
[TBL] [Abstract][Full Text] [Related]
23. Synergistic inhibitory effects of deferasirox in combination with decitabine on leukemia cell lines SKM-1, THP-1, and K-562.
Li N; Chen Q; Gu J; Li S; Zhao G; Wang W; Wang Z; Wang X
Oncotarget; 2017 May; 8(22):36517-36530. PubMed ID: 28388554
[TBL] [Abstract][Full Text] [Related]
24. Azacitidine regulates DNA methylation of GADD45γ in myelodysplastic syndromes.
Yang Y; Li J; Geng Y; Liu L; Li D
J Clin Lab Anal; 2021 Feb; 35(2):e23597. PubMed ID: 33080073
[TBL] [Abstract][Full Text] [Related]
25. 5-Aza-2'-Deoxycytidine and CDDP Synergistically Induce Apoptosis in Renal Carcinoma Cells via Enhancing the APAF-1 Activity.
Zhu X; Yi F; Chen P; Chen L; Zhang X; Cao C; Tan W
Clin Lab; 2015; 61(12):1821-30. PubMed ID: 26882803
[TBL] [Abstract][Full Text] [Related]
26. Decitabine Induces Change of Biological Traits in Myelodysplastic Syndromes via FOXO1 Activation.
Zhang Z; Jia Y; Xv F; Song LX; Shi L; Guo J; Chang CK
Front Genet; 2020; 11():603956. PubMed ID: 33584800
[TBL] [Abstract][Full Text] [Related]
27. Characterization of DNA demethylation effects induced by 5-Aza-2'-deoxycytidine in patients with myelodysplastic syndrome.
Mund C; Hackanson B; Stresemann C; Lübbert M; Lyko F
Cancer Res; 2005 Aug; 65(16):7086-90. PubMed ID: 16103056
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of resistance to decitabine in the myelodysplastic syndrome.
Qin T; Castoro R; El Ahdab S; Jelinek J; Wang X; Si J; Shu J; He R; Zhang N; Chung W; Kantarjian HM; Issa JP
PLoS One; 2011; 6(8):e23372. PubMed ID: 21858090
[TBL] [Abstract][Full Text] [Related]
29. Low dose decitabine treatment induces CD80 expression in cancer cells and stimulates tumor specific cytotoxic T lymphocyte responses.
Wang LX; Mei ZY; Zhou JH; Yao YS; Li YH; Xu YH; Li JX; Gao XN; Zhou MH; Jiang MM; Gao L; Ding Y; Lu XC; Shi JL; Luo XF; Wang J; Wang LL; Qu C; Bai XF; Yu L
PLoS One; 2013; 8(5):e62924. PubMed ID: 23671644
[TBL] [Abstract][Full Text] [Related]
30. Decitabine Enhances Acute Myeloid Leukemia Cell Apoptosis through SH3BGRL Upregulation.
Chen X; Liu F; Rong D; Xu L; Tong X; Wang H
Anticancer Agents Med Chem; 2022; 22(12):2274-2281. PubMed ID: 34963436
[TBL] [Abstract][Full Text] [Related]
31. All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RARα-Nrf2 complex.
Wang L; Zhang Q; Ye L; Ye X; Yang W; Zhang H; Zhou X; Ren Y; Ma L; Zhang X; Mei C; Xu G; Li K; Luo Y; Jiang L; Lin P; Zhu S; Lang W; Wang Y; Shen C; Han Y; Liu X; Yang H; Lu C; Sun J; Jin J; Tong H
Br J Cancer; 2023 Feb; 128(4):691-701. PubMed ID: 36482192
[TBL] [Abstract][Full Text] [Related]
32. 5-Aza-2'-deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53-independent apoptosis in myeloid leukemia.
Schmelz K; Wagner M; Dörken B; Tamm I
Int J Cancer; 2005 May; 114(5):683-95. PubMed ID: 15609309
[TBL] [Abstract][Full Text] [Related]
33. In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia: review of cytogenetic and molecular studies.
Hackanson B; Robbel C; Wijermans P; Lübbert M
Ann Hematol; 2005 Dec; 84 Suppl 1():32-8. PubMed ID: 16292549
[TBL] [Abstract][Full Text] [Related]
34. [Effects of uroacitides on the methylation of PTEN gene in myelodysplastic syndrome cells and its mechanism].
Huang J; Yang M; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2013 Jul; 34(7):600-5. PubMed ID: 23906454
[TBL] [Abstract][Full Text] [Related]
35. Role of heme oxygenase-1 in demethylating effects on SKM-1 cells induced by decitabine.
Gao R; Ma D; Wang P; Sun J; Wang JS; Fang Q
Genet Mol Res; 2015 Dec; 14(4):17788-98. PubMed ID: 26782424
[TBL] [Abstract][Full Text] [Related]
36. Artesunate-enhanced apoptosis of human high-risk myelodysplastic cells induced by the DNA methyltransferase inhibitor decitabine.
Wang Y; Wang F; Wen S; Guo Y; Liu X; Zhang X; Pan L
Oncol Lett; 2015 Jun; 9(6):2449-2454. PubMed ID: 26137088
[TBL] [Abstract][Full Text] [Related]
37. [Inhibitory Effect of Decitabine on Proliferation of MDS-L Cells and Its Mechanism].
Wu D; Zhang Y; Zhao YS; Guo J; Chang CK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1471-1476. PubMed ID: 29070127
[TBL] [Abstract][Full Text] [Related]
38. 5-Aza-2'-deoxycytidine, a DNA methylation inhibitor, attenuates hypoxic pulmonary hypertension via demethylation of the PTEN promoter.
Xing XQ; Li B; Xu SL; Zhang CF; Liu J; Deng YS; Yang J
Eur J Pharmacol; 2019 Jul; 855():227-234. PubMed ID: 31085236
[TBL] [Abstract][Full Text] [Related]
39. Decitabine promotes apoptosis in mesenchymal stromal cells isolated from patients with myelodysplastic syndromes by inducing reactive oxygen species generation.
Wang L; Guo X; Guo X; Zhang X; Ren J
Eur J Pharmacol; 2019 Nov; 863():172676. PubMed ID: 31542488
[TBL] [Abstract][Full Text] [Related]
40. Antiproliferative and antitumor effects of azacitidine against the human myelodysplastic syndrome cell line SKM-1.
Kimura S; Kuramoto K; Homan J; Naruoka H; Ego T; Nogawa M; Sugahara S; Naito H
Anticancer Res; 2012 Mar; 32(3):795-8. PubMed ID: 22399596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
